Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life

Figure 2

Change in mean arterial blood pressure during the 15 minute intravenous infusion of normal saline or respective bradykinin B2 agonist. NS, Normal Saline (N = 5); BK, Bradykinin (N = 5); Lys-BK, lysine-bradykinin (N = 7); Met-Lys-BK, methionine-lysine-bradykinin (N = 5); Labradimil (N = 11). Error bars represent standard deviation.

Back to article page